Cargando…

Hypofractionated intensity-modulated radiotherapy in patients with localized prostate cancer: a preliminary study

PURPOSE: The aim of this work was to assess the efficacy and tolerability of hypofractionated intensity-modulated radiotherapy (IMRT) in patients with localized prostate cancer. MATERIALS AND METHODS: Thirty-nine patients who received radical hypofractionated IMRT were retrospectively reviewed. Base...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Hye Jin, Kay, Chul-Seung, Son, Seok Hyun, Kim, Myungsoo, Jo, In Young, Lee, So Jung, Lee, Dong Hwan, Suh, Hong Jin, Choi, Yong Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Radiation Oncology 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831968/ https://www.ncbi.nlm.nih.gov/pubmed/27104166 http://dx.doi.org/10.3857/roj.2016.34.1.45

Ejemplares similares

Prognostic value of nodal SUV(max) of (18)F-FDG PET/CT in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Lee, So Jung, et al.
Publicado: (2017)

Treatment outcome of localized prostate cancer by 70 Gy hypofractionated intensity-modulated radiotherapy with a customized rectal balloon
por: Kim, Hyunjung, et al.
Publicado: (2014)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
por: Kim, Myungsoo, et al.
Publicado: (2014)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report
por: Cha, Jihye, et al.
Publicado: (2014)

The technical feasibility of an image-guided intensity-modulated radiotherapy (IG-IMRT) to perform a hypofractionated schedule in terms of toxicity and local control for patients with locally advanced or recurrent pancreatic cancer
por: Son, Seok Hyun, et al.
Publicado: (2012)

Review of Hypofractionated Radiotherapy for Prostate Cancer
por: Spyropoulou, Despina, et al.
Publicado: (2012)

The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastases
por: Jo, In-Young, et al.
Publicado: (2014)

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
por: Thomson, David, et al.
Publicado: (2012)

Phase II Trial of Pure Hypofractionated Radiotherapy in the Treatment of Localized Carcinoma of the Prostate
por: Gopaul, Darin, et al.
Publicado: (2018)

Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer
por: Lazo, Antonio, et al.
Publicado: (2022)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
por: Cho, L. Chinsoo, et al.
Publicado: (2013)

Reduced volume intensity-modulated radiotherapy with simultaneous integrated boost for patients with high-grade glioma: A retrospective observational study
por: Kang, Hye Jin, et al.
Publicado: (2023)

Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016)

Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer
por: Johansson, Silvia, et al.
Publicado: (2012)

Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future Prospectives
por: Lo Greco, Maria Chiara, et al.
Publicado: (2023)

Long-term outcome of hypofractionated intensity-modulated radiotherapy using TomoTherapy for localized prostate cancer: A retrospective study
por: Takakusagi, Yosuke, et al.
Publicado: (2019)

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer
por: Phak, Jeong Hoon, et al.
Publicado: (2016)

Automated prediction of dosimetric eligibility for hypofractionated prostate radiotherapy
por: Lausch, Anthony, et al.
Publicado: (2017)

Intrafraction Prostate Motion Management for Ultra-Hypofractionated Radiotherapy of Prostate Cancer
por: Oehler, Christoph, et al.
Publicado: (2022)

Hypofractionated Radiotherapy as Local Hemostatic Agent in Advanced Cancer
por: Rasool, Malik Tariq, et al.
Publicado: (2011)

Hypofractionated ablative radiotherapy for locally advanced pancreatic cancer
por: Crane, Christopher H.
Publicado: (2016)

Hypofractionated intensity-modulated radiotherapy with concurrent chemotherapy for elderly patients with locally advanced pancreatic carcinoma
por: Iwai, Takahiro, et al.
Publicado: (2020)

Whole pelvic intensity-modulated radiotherapy for high-risk prostate cancer: a preliminary report
por: Joo, Ji Hyeon, et al.
Publicado: (2013)

MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer
por: Cuccia, Francesco, et al.
Publicado: (2021)

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
por: Tamihardja, Jörg, et al.
Publicado: (2020)

Long-term outcome of a moderately hypofractionated, intensity-modulated radiotherapy approach using an endorectal balloon for patients with localized prostate cancer
por: Teh, Bin S., et al.
Publicado: (2018)

Extreme Hypofractionation with SBRT in Localized Prostate Cancer
por: Gómez-Aparicio, Maria Antonia, et al.
Publicado: (2021)

Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy
por: Song, Jin Ho, et al.
Publicado: (2015)

Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer
por: He, Jiaoxue, et al.
Publicado: (2023)

Evolution of Hypofractionated Accelerated Radiotherapy for Prostate Cancer – The Sunnybrook Experience
por: Musunuru, Hima Bindu, et al.
Publicado: (2014)

Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?
por: Mahase, Sean, et al.
Publicado: (2020)

Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in Africa
por: Swanson, William, et al.
Publicado: (2021)

Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey
por: Sabbagh, Ali, et al.
Publicado: (2023)

Moderate hypofractionation for prostate cancer
por: Lee, W. Robert, et al.
Publicado: (2018)

Moderate hypofractionated radiotherapy is more effective and safe for localized prostate cancer patients: a meta-analysis
por: Cao, Ling, et al.
Publicado: (2016)

Late results of a randomized trial on the role of mild hypofractionated radiotherapy for the treatment of localized prostate cancer
por: Alexidis, Petros, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r0hghfk93kn9nmm0hsh648id6v